Search Results 1241-1250 of 19366 for hemoglobin

1. Ixazomib Citrate, Lenalidomide, Dexamethasone, and Zoledronic Acid or Zoledronic Acid Alone After Radiation Therapy in Treating Patients With Solitary Plasmacytoma of Bone - Mayo Clinic

   Hemoglobin ≥ 10 g/dL;; Serum Creatinine < 2.0 mg/dL [176.8 µmol/liter];; Serum calcium ≤ 11.5 mg/dL;; Calc. Creatinine Clearance > 50 mL/min;; Bilirubin ...

2. Bortezomib and Combination Chemotherapy in Treating Younger Patients With Recurrent, Refractory, or Secondary Acute Myeloid Leukemia - Mayo Clinic

   FVC and DLCO > 50% (corrected for hemoglobin). Patients who are unable to perform pulmonary function tests (PFTs) (e.g., because of young age) will be ...

3. Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ANX005 in Subjects With Warm Autoimmune Hemolytic Anemia (wAIHA) - Mayo Clinic

   - Hemoglobin (Hgb) level ≤10.0 grams/deciliter (pre-transfusion). - Evidence of classical complement pathway activation. - Evidence of active hemolysis ...

4. A Study of Abemaciclib (LY2835219) in Women With HR+, HER2+ Locally Advanced or Metastatic Breast Cancer - Mayo Clinic

   ... hemoglobin ≥ 8 g/dL. Patients may receive erythrocyte transfusions to achieve this hemoglobin level at the discretion of the investigator. Initial ...

5. Prescription of Letrozole for Uterine Myoma - Mayo Clinic

   * Screening serum hemoglobin \<8 g/dL, or history of blood transfusion in the last 12 weeks (indicating severe anemia) * Screening cholesterol lipid panel ...

6. A Study of Ubenimex in Patients with Pulmonary Arterial Hypertension - Mayo Clinic

   Hemoglobin concentration <9 g/dL at screening; Hepatic dysfunction as defined by Child-Pugh Class B or C. Participating Mayo Clinic locations. Study statuses ...

7. Testing Whether Treating Breast Cancer Metastases With Surgery or High-Dose Radiation Improves Survival - Mayo Clinic

   Hemoglobin ≥ 8.0 g/dl: The use of transfusion or other intervention to achieve hemoglobin [Hgb] ≥ 8.0 g/dl is acceptable. For females of child-bearing ...

8. A Study to Evaluate the Safety and Effectiveness of Metformin and Nelfinavir with Bortezomib in Patients with Relapsed and/or Refractory Multiple Myeloma - Mayo Clinic

   Hemoglobin ≥ 8.0 g/dL (No red cell transfusion should have been administered within 4 days of registration);; Absolute neutrophil count (ANC) ≥ 1000/mm^3 ...

9. Cediranib Maleate and Selumetinib in Treating Patients With Solid Malignancies - Mayo Clinic

   Hemoglobin (HgB) ≥ 9.0 gm/dL; Alkaline phosphatase ≤ 2.5 x ULN; Creatinine clearance > 50 ml/min, by either Cockcroft-Gault formula or 24-hour urine ...

10. Fuchs Clinical Trials - Mayo Clinic Research

    ... hemoglobin A1c (HbA1c), and skin advanced glycation endproducts (AGE) and ... . Mayo Clinic Footer. Request Appointment · Give Now · Contact Us · About Mayo ...